Home
January 2010 February 2010 March 2010
Su Mo Tu We Th Fr Sa
Week 5 1 2 3 4 5 6
Week 6 7 8 9 10 11 12 13
Week 7 14 15 16 17 18 19 20
Week 8 21 22 23 24 25 26 27
Week 9 28

The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients - Abstract Show Comments PDF Print E-mail
  
Thursday, 29 October 2009

Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.

This email address is being protected from spam bots, you need Javascript enabled to view it

Utilization of nuclear bone scans for staging newly diagnosed prostate cancer has decreased dramatically due to PSA-driven stage migration. The current criteria for performing bone scans are based on limited historical data. This study evaluates serum PSA and Gleason grade in predicting positive scans in a contemporary large series of newly diagnosed prostate cancer patients. Eight hundred consecutive cases of newly diagnosed prostate cancer over a 64-month period underwent a staging nuclear scan. All subjects had histologically confirmed cancer. The relationship between PSA, Gleason grade, and bone scan was examined by calculating series of crude, stratified, and adjusted odds ratios with corresponding 95% confidence intervals. Four percent (32/800) of all bone scans were positive. This proportion was significantly lower in patients with Gleason score < or=7 (1.9%) vs. Gleason score >or=8 (18.8%, p < 0.001). Among patients with Gleason score < or=7, the rate of positive bones scans was 70-fold higher when the PSA was >30 ng/ml compared to < or=30 ng/ml (p < 0.001). For Gleason score >or=8, the rate was significantly higher (27.9 vs. 0%) when PSA was >10 ng/ml compared to < or=10 ng/ml (p = 0.002). The combination of Gleason score and PSA enhances predictability of bone scans in newly diagnosed prostate cancer patients. The PSA threshold for ordering bone scans should be adjusted according to Gleason score. For patients with Gleason scores < or=7, we recommend a bone scan if the PSA is >30 ng/ml. However, for patients with a high Gleason score (8-10), we recommend a bone scan if the PSA is >10 ng/ml.

Written by:
Ritenour CW, Abbott JT, Goodman M, Alazraki N, Marshall FF, Issa MM.   Are you the author?

Reference:
ScientificWorldJournal. 2009 Oct 2;9:1040-5.
doi:10.1100/tsw.2009.113

PubMed Abstract
PMID:19802499

UroToday.com Prostate Cancer Section


Submit Comments
 
User Rating: / 2
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
5 (1 votes)

Patients:
5 (1 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search